An elevated level of serum C-reactive protein (CRP), an acute-phase reactant, has been found to predict the clinical outcome of various cardiovascular diseases such as myocardial infarction and stroke in the general population and in patients with chronic kidney disease and those undergoing dialysis [1], [2]. Here, CRP is linked to myocardial infarction.